| Name | n-(4,5-bis-methansulfonyl-2-methyl-benzoyl)-guanidin, hydrochlorid |
|---|---|
| Synonyms | Rimeporide Hydrochloride |
| Description | Rimeporide hydrochloride is a potent and selective inhibitor of the Na+/H+ exchanger (NHE-1). |
|---|---|
| Related Catalog | |
| Target |
NHE1[1] |
| In Vitro | Blocking NHE-1 activity has been shown to decrease intracellular Na+ and Ca2+ overload and pH and Rimeporide represents a new therapeutic option for duchenne muscular dystrophy (DMD). Rimeporide is expected to act as a muscle-sparing agent and its mode of action means that it is mutation independent[1]. |
| References |
| Molecular Formula | C11H16ClN3O5S2 |
|---|---|
| Molecular Weight | 369.84500 |
| Exact Mass | 369.02200 |
| PSA | 164.01000 |
| LogP | 3.57980 |